相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe
Gonzalo Gutierrez-Garcia et al.
BONE MARROW TRANSPLANTATION (2020)
Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen
Takumi Hoshino et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Olle Ringden et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation
Celalettin Ustun et al.
BONE MARROW TRANSPLANTATION (2019)
Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease
Clint Piper et al.
FRONTIERS IN IMMUNOLOGY (2019)
Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation
Olle Ringden et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease
Evelyn Ullrich et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells
Sonia Tugues et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2
Dimitry A. Chistiakov et al.
IMMUNOBIOLOGY (2017)
Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions
Johan Torlen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission
Masamitsu Yanada et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Johan Torlen et al.
HAEMATOLOGICA (2016)
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice
Yusuke Shono et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Johan Torlen et al.
HAEMATOLOGICA (2016)
Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults
Thomas Poiret et al.
BMC IMMUNOLOGY (2014)
Many Days at Home during Neutropenia after Allogeneic Hematopoietic Stem Cell Transplantation Correlates with Low Incidence of Acute Graft-versus-Host Disease
Olle Ringden et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Significance of Ethnicity in the Risk of Acute Graft-versus-Host Disease and Leukemia Relapse after Unrelated Donor Hematopoietic Stem Cell Transplantation
Yasuo Morishima et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Pre-engraftment blood stream infection is a risk factor for acute GVHD grades II-IV
O. Blennow et al.
BONE MARROW TRANSPLANTATION (2013)
A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
O. Ringden et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation
Ulrica Forslow et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Role of Cytokines in the Pathophysiology of Acute Graft-Versus-Host Disease (GVHD)-Are Serum/Plasma Cytokines Potential Biomarkers for Diagnosis of Acute GVHD Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)?
Tomomi Toubai et al.
CURRENT STEM CELL RESEARCH & THERAPY (2012)
The incidence of acute graft-versus-host disease increases with Candida colonization depending the dectin-1 gene status
Walter J. F. M. van der Velden et al.
CLINICAL IMMUNOLOGY (2010)
Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver
M. Remberger et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplants
Richard Olsson et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Granulocyte Colony-Stimulating Factor Induced Acute and Chronic Graft-Versus-Host Disease
Olle Ringden et al.
TRANSPLANTATION (2010)
Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia
Olle Ringden et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
Juergen Finke et al.
LANCET ONCOLOGY (2009)
Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation
Edward S. Morris et al.
NATURE MEDICINE (2009)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Association of Serum Interleukin-7 Levels With the Development of Acute Graft-Versus-Host Disease
Robert M. Dean et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Vascular endothelial growth factor and activin-A serum levels following allogeneic hematopoietic stem cell transplantation
David Nachbaur et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases
O. Ringden et al.
BONE MARROW TRANSPLANTATION (2007)
Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation
C-K Min et al.
BONE MARROW TRANSPLANTATION (2006)
Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades
Britt-Marie Svahn et al.
TRANSPLANTATION (2006)
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors
U Hegenbart et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation
BM Svahn et al.
BONE MARROW TRANSPLANTATION (2005)
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death:: A study from the acute leukemia working party of the European Group for Blood and Marrow Transplantation
O Ringdén et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation
WJ Jordan et al.
BLOOD (2004)
Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation
M Schaffer et al.
TISSUE ANTIGENS (2003)
Immunobiology of acute graft-versus-host disease
P Reddy et al.
BLOOD REVIEWS (2003)
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care
BM Svahn et al.
BLOOD (2002)
分享论文
